Xynomic Pharma Reports Encouraging Interim Data from Phase 1b Study of Abexinostat Combined with Keytruda® in Multiple Solid Tumors

August 30, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search